Language
Country/Area
No result found
The mysterious power of Lantus insulin: Why is it the first choice for diabetes treatment?
Globally, the number of diabetes patients is increasing, and how to effectively control blood sugar levels has become an important public health issue. Among many treatment options, Lantus insulin, with its long-acting effect and ease of use, has become the first choice for many patients. What is unique about this insulin? Let’s take a deeper look at the features and benefits of Lantus.
Insulin is an important hormone that controls blood sugar, and Lantus is a major innovation in modern medicine.
What is Lantus insulin?
Lantus, also known as Insulin Glargine, is a long-acting, modified form of insulin used primarily for the management of type 1 and type 2 diabetes. It is injected subcutaneously and usually begins to work about an hour after injection and lasts for about 24 hours.
Lantus works by causing body tissues to absorb glucose from the blood and by reducing glucose production by the liver.
Advantages of using Lantus
The main advantage of Lantus is that it provides stable blood sugar control, which is essential for the long-term management of diabetes. According to the data, Lantus can not only effectively lower blood sugar, but is also clinically considered to have relative control over the risk of hypoglycemia. This makes Lantus the first choice for many physicians and patients, especially those who want to manage their blood sugar without suffering the discomfort of hypoglycemia.
Side effects and risks
While Lantus has several advantages over other insulins, users should be aware of some common side effects, including low blood sugar, injection site problems, itching and weight gain. In addition, Lantus users may occasionally experience more serious side effects such as hypokalemia.
According to research, the overall side effects of Lantus in the treatment of diabetes are no more significant than those of NPH insulin or other long-acting insulins.
Mechanism and clinical research
The mechanism of action of Lantus lies in the change of its structure, which makes it more soluble in acidic environment and slows down the release. In the neutral environment of the subcutaneous space, Lantus forms advanced aggregates, resulting in a slow, sustained release of insulin from the injection site. This release pattern means that patients do not need to take multiple injections in a day, increasing the convenience of use.
History of Lantus
Lantus was approved in the United States in 2000 and has subsequently become one of the most commonly used long-acting insulins on the market. Since its patent expired in 2014, other manufacturers have begun to launch their own similar products, such as Semglee, which provides patients with more choices and market competition.
The emergence of biosimilar products
With the expiration of the Lantus patent, many biosimilar drugs have been launched. These products, such as Abasaglar and Semglee, not only provide more price-competitive options to the market, but also help patients reduce their healthcare expenses.
About the future of Lantus
Lantus' position in the industry appears secure in the face of changing diabetes treatment needs. Researchers and healthcare providers are still exploring new methods of use and side effect management strategies to further optimize diabetes control. As technology advances, more advanced long-acting insulins may become available in the future.
Lantus represents a major breakthrough in modern medicine for the treatment of diabetes. Will we be able to further improve the effectiveness of diabetes management in the future?
Whether in terms of economic benefits, ease of use or efficacy, Lantus insulin does play an important role, making it an ideal choice for diabetic patients in managing blood sugar. When faced with so many options, how can we ensure that we choose the most appropriate treatment option?
